The same trend was found in monocytes treated with Th2 milieu (LTA+alpha-toxin+IL-4, IL-5, and IL-13), suggesting that NLRP3 inflammasome impairment might contribute to skin inflammation in AD (110) (Figure 2). This evidence concerns the gene NLRP3 and Alzheimer disease.